TCL Archive Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis December 27, 2013
TCL Archive Cancer Leadership Council Letter Calls For Permanent Leadership of NCI and FDA. November 22, 2006